RT  - European Journal of Gynaecological Oncology
ID  - 10.31083/j.ejgo.2020.03.5197
T1  - Is the Risk of Malignancy Index a predictive tool for preoperative differentiation between borderline ovarian tumor and ovarian cancer?
A1  - S.R Oh
A1  - J.-W. Park
K1  - Risk of Malignancy Index; Preoperative diagnosis; Borderline ovarian tumor; Ovarian cancer
YR  - 2020
SP  - 368
AB  - <p><i>Purpose:</i> To determine an appropriate Risk of Malignancy Index (RMI) cutoff value by comparative analysisof the four malignancy risk indices for distinguishing between borderline ovarian tumor (BOT) and ovarian cancer (OC). <i>Materials and Methods:</i> Retrospective analysis of the medical records of 339 patients (115 BOTsand 224 OCs). <i>Results:</i> There were no significant differences in the area under the ROC curve (AUC) for RMI 1, RMI 2, RMI 3, and RMI 4 (0.792, 0.791, 0.785, and 0.785, respectively). However, the diagnostic capability of the RMI was significantly greater than that of other factors. <i>Conclusion:</i> This study is the first to investigate the performance of the four Risk of Malignancy Indices for distinguishing between BOT and invasive OC. Although there were no significant differences between RMI scores, the RMIs were very effective at predicting an accurate preoperative diagnosis in patients with all BOT and OC histotypes.</p>